Johnson & Johnson Secures FDA Approval for Dual-Energy Catheter Ablation Platform
Shots:
- The US FDA has approved Dual Energy THERMOCOOL SMARTTOUCH SF (DE STSF) Platform, an integrated catheter ablation system that enables delivery of both radiofrequency (RF) & pulsed field (PF) energy through a single catheter
- Built on the THERMOCOOL SMARTTOUCH SF Platform, used in >1M US pts, the dual-energy system integrates with the CARTO ecosystem & enables physicians to choose RF or PF energy based on patient anatomy & procedural complexity
- J&J MedTech expects the first US procedures using the DE STSF Platform to begin this summer as it initiates a phased commercial rollout
Ref: Businesswire | Image: J&J | Press Release
Related News: Johnson & Johnson launches ACUVUE OASYS MAX 1-Day MULTIFOCAL for ASTIGMATISM Contact Lens in the US and Canada
PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com


